“Clinical Efficacy or Tildrakizumab in Patients With Chronic Plaque Psoriasis Over 2 Years of Treatment: Results from Long-Term Extensions to 2 Phase 3 Clinical Studies”. 2018. SKIN The Journal of Cutaneous Medicine 2 (S1): S4. https://doi.org/10.25251/skin.2.supp.4.